Moffitt Cancer CenterTampa, FL
Disclosures:
2542 - Multi-Institutional Report of Trastuzumab-Deruxtecan and Stereotactic Radiosurgery for HER2+ Breast Cancer Brain Metastases
Monday, September 30, 202410:45 AM – 12:00 PM ET
3204 - Intermediate Term Urinary Outcomes Following Prostate Radiation Therapy after Neoadjuvant Prostate Artery Embolization
Tuesday, October 1, 20242:30 PM – 3:45 PM ET